Overview of Morin and Its Complementary Role as an Adjuvant for Anticancer Agents

References

• Fouad YA, Aanei C. Revisiting the hallmarks of cancer. Am J Cancer Res. 2017;7(5):1016–1036.
   PubMed Web of Science ®Google Scholar
• Kannappan R, Gupta SC, Kim JH, Aggarwal BB. Tocotrienols fight cancer by targeting multiple cell signaling pathways. Genes Nutr. 2012;7(1):43–52. doi:10.1007/s12263-011-0220-3
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.21442
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer (IARC). Latest global cancer data, 2018. Geneva, Switzerland: World Health Organization; 2018.
   Google Scholar
• Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, et al. Oncogenic signaling pathways in the cancer genome atlas. Cell. 2018;173(2):321–37.e10. doi:10.1016/j.cell.2018.03.035
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman R. a, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–18. doi:10.1021/mp700113r
   PubMed Web of Science ®Google Scholar
• Duffy R, Wade C, Chang R. Discovery of anticancer drugs from antimalarial natural products: a MEDLINE literature review. Drug Discov Today. 2012;17(17–18):942–53. doi:10.1016/j.drudis.2012.03.013
   PubMed Web of Science ®Google Scholar
• Rasouli H, Farzaei MH, Khodarahmi R. Polyphenols and their benefits: a review. Int J Food Prop. 2017:20(Sup 2):1700-1741.. doi:10.1080/10942912.2017.1354017
   Web of Science ®Google Scholar
• Afzal M, Safer AM, Menon M. Green tea polyphenols and their potential role in health and disease. Inflammopharmacology. 2015;23(4):151–61. doi:10.1007/s10787-015-0236-1
   PubMed Web of Science ®Google Scholar
• Li A-N, Li S, Zhang Y-J, Xu X-R, Chen Y-M, Li H-B. Resources and biological activities of natural polyphenols. Nutrients. 2014;6(12):6020–47. doi:10.3390/nu6126020
   PubMed Web of Science ®Google Scholar
• Tomás-Barberán FA, Andrés-Lacueva C. Polyphenols and health: Current state and progress. J Agric Food Chem. 2012;60(36):8773–5. doi:10.1021/jf300671j
   PubMed Web of Science ®Google Scholar
• Thirugnanasambantham P, Viswanathan S, Ramaswamy S, Krishnamurty V, Mythirayee C, Kameswaran L. Analgesic activity of certain flavone derivatives: a structure-activity study. Clin Exp Pharmacol Physiol. 1993;20(1):59–63. doi:10.1111/j.1440-1681.1993.tb01503.x
   PubMed Web of Science ®Google Scholar
• Saminathan M, Rai RB, Dhama K, Tiwari R, Chakrabort S, A, Ranganath GJ, Kannan K. Systematic review on anticancer potential and other health beneficial pharmacological activities of novel medicinal plant Morin da citrifolia (Noni). Int J Pharmacol. 2013;9(8):462–92. doi:10.3923/ijp.2013
   Google Scholar
• Gravina HD, Tafuri NF, Silva Júnior A, Fietto JLR, Oliveira TT, Diaz MAN, Almeida MR. In vitro assessment of the antiviral potential of trans-cinnamic acid, quercetin and morin against equid herpesvirus 1. Res Vet Sci. 2011;91(3):e158–62. doi:10.1016/j.rvsc.2010.11.010
   PubMed Web of Science ®Google Scholar
• Lemkul JA, Bevan DR. Morin inhibits the early stages of amyloid β-peptide aggregation by altering tertiary and quaternary interactions to produce “off-pathway” structures. Biochemistry. 2012;51(30):5990–6009. doi:10.1021/bi300113x
   PubMed Web of Science ®Google Scholar
• Yu Z, Fong WP, Cheng C. The dual actions of morin (3,5,7,2',4'-pentahydroxyflavone) as a hypouricemic agent: uricosuric effect and xanthine oxidase inhibitory activity. J Pharmacol Exp Ther. 2006;316(1):169–75. doi:10.1124/jpet.105.092684
   PubMed Web of Science ®Google Scholar
• Dixon M, Woodrick J, Gupta S, Karmahapatra SK, Devito S, Vasudevan S, Dakshanamurthy S, Adhikari S, Yenugonda VM, Roy R, et al. Naturally occurring polyphenol, morin hydrate, inhibits enzymatic activity of N-methylpurine DNA glycosylase, a DNA repair enzyme with various roles in human disease. Bioorg Med Chem. 2015;23(5):1102–11. doi:10.1016/j.bmc.2014.12.067
   PubMed Web of Science ®Google Scholar
• Abuohashish HM, Al-Rejaie SS, Al-Hosaini K. a, Parmar MY, Ahmed MM. Alleviating effects of morin against experimentally-induced diabetic osteopenia. Diabetol Metab Syndr. 2013;5(1):5doi:10.1186/1758-5996-5-5
   PubMed Web of Science ®Google Scholar
• Venu Gopal J. Morin Hydrate: Botanical origin, pharmacological activity and its applications: A mini-review. Pharmacogn J. 2013;5(3):123–6. doi:10.1016/j.phcgj.2013.04.006
   Google Scholar
• Caselli A, Cirri P, Santi A, Paoli P. Morin: a promising natural drug. Curr Med Chem. 2016;23(8):774–91. doi:10.2174/0929867323666160106150821
   PubMed Web of Science ®Google Scholar
• Pandey MM, Rastogi S, Rawat A. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid Based Complement Alternat Med. 2013;2013:376327. doi:10.1155/2013/376327
   PubMed Web of Science ®Google Scholar
• Xie M-X, Long M, Liu Y, Qin C, Wang YD. Characterization of the interaction between human serum albumin and morin. Biochim Biophys Acta. 2006;1760(8):1184–91. doi:10.1016/j.bbagen.2006.03.026
   PubMed Web of Science ®Google Scholar
• Merwid-La̧D A, Trocha M, Chlebda E, Sozański T, Magdalan J, et al. Effects of morin-5′-sulfonic acid sodium salt (NaMSA) on cyclophosphamide-induced changes in oxido-redox state in rat liver and kidney. Hum Exp Toxicol. 2012;31(8):812-19. doi:10.1177/0960327111431090
   PubMed Web of Science ®Google Scholar
• Calvaresi EC, Hergenrother PJ. Glucose conjugation for the specific targeting and treatment of cancer. Chem Sci. 2013;4(6):2319. doi:10.1039/c3sc22205e
   PubMed Web of Science ®Google Scholar
• Choudhury A, Chakraborty I, Banerjee TS, Vana DR, Adapa D. Efficacy of morin as a potential therapeutic phytocomponent: insights into the mechanism of action. Int J Med Res Health Sci. 2017;6(11):175–194.
   Web of Science ®Google Scholar
• Fang S-H, Hou Y-C, Chang W-C, Hsiu S-L, Chao P-DL, Chiang B-L. Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci. 2003;74(6):743–56. doi:10.1016/j.lfs.2003.07.017
   PubMed Web of Science ®Google Scholar
• Waddad AY, Abbad S, Yu F, Munyendo WLL, Wang J, Lv H, Zhou J. Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants. Int J Pharm. 2013;456(2):446–58. doi:10.1016/j.ijpharm.2013.08.040
   PubMed Web of Science ®Google Scholar
• Sahu K, Shaharyar M, Siddiqui AA. Effect of Morin on pharmacokinetics of Piracetam in rats, in vitro enzyme kinetics and metabolic stability assay using rapid UPLC method. Drug Test Anal. 2013;5(7):581–8. doi:10.1002/dta.1382
   PubMed Web of Science ®Google Scholar
• Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010;44(5):479–96. doi:10.3109/10715761003667554
   PubMed Web of Science ®Google Scholar
• Kumari S, Badana AK, Murali Mohan G, Shailender G, Malla RR. Reactive oxygen species: a key constituent in cancer survival. Biomarker Insights. 2018;13:1177271918755391. 1 doi:10.1177/:117727191875539
   Web of Science ®Google Scholar
• Galadari S, Rahman A, Pallichankandy S, Thayyullathil F. Reactive oxygen species and cancer paradox: To promote or to suppress?. Free Radic Biol Med. 2017;104:144–64. doi:10.1016/j.freeradbiomed.2017.01.004
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;6(11):175-194. doi:10.1016/j.biocel.2006.07.001
   PubMed Web of Science ®Google Scholar
• Sciacovelli M, Frezza C. Oncometabolites: unconventional triggers of oncogenic signalling cascades. Free Radic Biol Med. 2016;100:175–81. doi:10.1016/j.freeradbiomed.2016.04.025
   PubMed Web of Science ®Google Scholar
• Kanakis CD, Nafisi S, Rajabi M, Shadaloi A, Tarantilis PA, Polissiou MG, Bariyanga J, Tajmir-Riahi HA. Structural analysis of DNA and RNA interactions with antioxidant flavonoids. Spectroscopy. 2009;23(1):29–43. doi:10.3233/SPE-2009-0368
   Web of Science ®Google Scholar
• Kim JM, Lee EK, Park G, Kim MK, Yokozawa T, Yu BP, Chung HY. Morin modulates the oxidative stress-induced NF-kappaB pathway through its anti-oxidant activity. Free Radic Res. 2010;44(4):454–61. doi:10.3109/10715761003610737
   PubMed Web of Science ®Google Scholar
• Rajendran M, Manisankar P, Gandhidasan R, Murugesan R. Free radicals scavenging efficiency of a few naturally occurring flavonoids: a comparative study. J Agric Food Chem. 2004;52(24):7389–94. doi:10.1021/jf0400718
   PubMed Web of Science ®Google Scholar
• Makris DP, Rossiter JT. An investigation on structural aspects influencing product formation in enzymic and chemical oxidation of quercetin and related flavonols. Food Chem. 2002;77(2):177–85. doi:10.1016/S0308-8146(01)00333-8
   Web of Science ®Google Scholar
• Zeng LH, Fung KP, Wu TW. Morin hydrate protects cultured rat glomerular mesangial cells against oxyradical damage. Life Sci. 1994;55(18):PL351–PL357. doi:10.1016/0024-3205(94)00760-8
   PubMed Web of Science ®Google Scholar
• Wu TW, Zeng LH, Wu J, Fung KP. Morin: a wood pigment that protects three types of human cells in the cardiovascular system against oxyradical damage. Biochem Pharmacol. 1994;47(6):1099–103. doi:10.1016/0006-2952(94)90424-3
   PubMed Web of Science ®Google Scholar
• Zeng LH, Rootman DS, Burnstein A, Wu J, Wu TW. Morin hydrate: A better protector than purpurogallin of corneal endothelial cell damage induced by xanthine oxidase and SIN-1. Curr Eye Res. 1998;17(2):149–52. doi:10.1076/ceyr.17.2.149.5600
   PubMed Web of Science ®Google Scholar
• Gottlieb M, Leal-Campanario R, Campos-Esparza MR, Sánchez-Gómez MV, Alberdi E, Arranz A, Delgado-García JM, Gruart A, Matute C. Neuroprotection by two polyphenols following excitotoxicity and experimental ischemia. Neurobiol Dis. 2006;23(2):374–86. doi:10.1016/j.nbd.2006.03.017
   PubMed Web of Science ®Google Scholar
• Sreedharan V, Venkatachalam KK, Namasivayam N. Effect of morin on tissue lipid peroxidation and antioxidant status in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis. Invest New Drugs. 2009;27(1):21–30. doi:10.1007/s10637-008-9136-1
   PubMed Web of Science ®Google Scholar
• Carneiro CD, Amorim JC, Cadena SMSC, Noleto GR, Di Mascio P, Rocha MEM, Martinez GR. Effect of flavonoids on 2’-deoxyguanosine and DNA oxidation caused by singlet molecular oxygen. Food Chem Toxicol. 2010;48(8–9):2380–7. doi:10.1016/j.fct.2010.05.075
   PubMed Web of Science ®Google Scholar
• Kuo HM, Chang LS, Lin YL, Lu HF, Yang JS. Morin inhibits the growth of human leukemia HL-60 cells via cell cycle arrest and induction of apoptosis through mitochondria dependent pathway. Anticancer Res. 2007;27(1A):395–405.
   PubMed Web of Science ®Google Scholar
• Sivaramakrishnan V, Devaraj SN. Morin fosters apoptosis in experimental hepatocellular carcinogenesis model. Chem Biol Interact. 2010;183(2):284–92. doi:10.1016/j.cbi.2009.11.011
   PubMed Web of Science ®Google Scholar
• Hsiang C-Y, Wu S-L, Ho T-Y. Morin inhibits 12-O-tetradecanoylphorbol-13-acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression. Biochem Pharmacol. 2005;69(11):1603–11. doi:10.1016/j.bcp.2005.03.008
   PubMed Web of Science ®Google Scholar
• Brown J, O'Prey J, Harrison PR. Enhanced sensitivity of human oral tumours to the flavonol, morin, during cancer progression: involvement of the Akt and stress kinase pathways. Carcinogenesis. 2003;24(2):171–7. doi:10.1093/carcin/24.2.171
   PubMed Web of Science ®Google Scholar
• Sivaramakrishnan V, Niranjali Devaraj S. Morin regulates the expression of NF-κB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chem Biol Interact. 2009;180(3):353–9. doi:10.1016/j.cbi.2009.02.004
   PubMed Web of Science ®Google Scholar
• Tanaka T, Kawabata K, Kakumoto M, Makita H, Ushida J, Honjo S, Hara A, Tsuda H, Mori H. Modifying effects of a flavonoid morin on azoxymethane-induced large bowel tumorigenesis in rats. Carcinogenesis. 1999;20(8):1477–84. doi:10.1093/carcin/20.8.1477
   PubMed Web of Science ®Google Scholar
• Kawabata K, Tanaka T, Honjo S, Kakumoto M, Hara A, Makita H, Tatematsu N, Ushida J, Tsuda H, Mori H. Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis. Int J Cancer. 1999;83(3):381–6. doi:10.1002/(SICI)1097-0215(19991029)83:3 < 381::AID-IJC14 > 3.0.CO;2-X
   PubMed Web of Science ®Google Scholar
• Nandhakumar R, Salini K, Niranjali Devaraj S. Morin augments anticarcinogenic and antiproliferative efficacy against 7,12-dimethylbenz(a)-anthracene induced experimental mammary carcinogenesis. Mol Cell Biochem. 2012;364(1-2):79–92. doi:10.1007/s11010-011-1207-5
   PubMed Web of Science ®Google Scholar
• MadanKumar P, NaveenKumar P, Manikandan S, Devaraj H, NiranjaliDevaraj S. Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/β-catenin signaling. Toxicol Appl Pharmacol. 2014;277(2):210–20. doi:10.1016/j.taap.2014.03.008
   PubMed Web of Science ®Google Scholar
• Kuo H-M, Chang L-S, Lin Y-L, Lu H-F, Yang J-S, Lee J-H, Chung J-G. Morin inhibits the growth of human leukemia HL-60 cells via cell cycle arrest and induction of apoptosis through mitochondria dependent pathway. Anticancer Res. 2007;27(1A):395–405.
   PubMed Web of Science ®Google Scholar
• Park C, Lee WS, Go S-I, Nagappan A, Han MH, Hong SH, Kim GS, Kim GY, Kwon TK, Ryu CH, et al. Morin, a flavonoid from moraceae, induces apoptosis by induction of BAD protein in human leukemic cells. Int J Mol Sci. 2014;16(1):645–59. doi:10.3390/ijms16010645
   PubMed Web of Science ®Google Scholar
• Manna SK, Aggarwal RS, Sethi G, Aggarwal BB, Ramesh GT. Morin (3,5,7,2',4'-Pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosis. Clin Cancer Res. 2007;13(7):2290–7. doi:10.1158/1078-0432.CCR-06-2394
   PubMed Web of Science ®Google Scholar
• García-Lafuente A, Guillamón E, Villares A, Rostagno MA, Martínez JA. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res. 2009;58(9):537–52. doi:10.1007/s00011-009-0037-3
   PubMed Web of Science ®Google Scholar
• MadanKumar P, NaveenKumar P, Devaraj H, Niranjali Devaraj S. Morin, a dietary flavonoid, exhibits anti-fibrotic effect and induces apoptosis of activated hepatic stellate cells by suppressing canonical NF-κB signaling. Biochimie. 2015;110:107–18. doi:10.1016/j.biochi.2015.01.002
   PubMed Web of Science ®Google Scholar
• Yuan CH, Filippova M, Tungteakkhun SS, Duerksen-Hughes PJ, Krstenansky JL. Small molecule inhibitors of the HPV16-E6 interaction with caspase 8. Bioorg Med Chem Lett. 2012;22(5):2125-2129. doi:10.1016/j.bmcl.2011.12.145
   Web of Science ®Google Scholar
• Gallus J, Juvale K, Wiese M. Characterization of 3-methoxy flavones for their interaction with ABCG2 as suggested by ATPase activity. Biochim et Biophys Acta - Biomembr. 2014;1838(11):2929-2938. doi:10.1016/j.bbamem.2014.08.003
   Web of Science ®Google Scholar
• Hyun H-B, Lee WS, Go S-I, Nagappan A, Park C, Han MH, Hong SH, Kim G, Kim GY, Cheong J, et al. The flavonoid morin from Moraceae induces apoptosis by modulation of Bcl-2 family members and Fas receptor in HCT 116 cells. Int J Oncol. 2015;46(6):2670–8. doi:10.3892/ijo.2015.2967
   PubMed Web of Science ®Google Scholar
• Gupta SC, Phromnoi K, Aggarwal BB. Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1. Biochem Pharmacol. 2013;85(7):898–912. doi:10.1016/j.bcp.2012.12.018
   PubMed Web of Science ®Google Scholar
• Chen W-P, Wang Y-L, Tang J-L, Hu P-F, Bao J-P, Wu L-D. Morin inhibits interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Int Immunopharmacol. 2012;12(2):447–52. doi:10.1016/j.intimp.2011.12.024
   PubMed Web of Science ®Google Scholar
• Sinha K, Sadhukhan P, Saha S, Pal PB, Sil PC. Morin protects gastric mucosa from nonsteroidal anti-inflammatory drug, indomethacin induced inflammatory damage and apoptosis by modulating NF-κB pathway. Biochim Biophys Acta. 2015;1850(4):769–83. doi:10.1016/j.bbagen.2015.01.008
   PubMed Web of Science ®Google Scholar
• Kempuraj D, Madhappan B, Christodoulou S, Boucher W, Cao J, Papadopoulou N, Cetrulo CL, Theoharides TC. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. 2005;145:934–44. doi:10.1038/sj.bjp.0706246
   Google Scholar
• Palchaudhuri R, Hergenrother PJ. DNA as a target for anticancer compounds : methods to determine the mode of binding and the mechanism of action. Curr Opin Biotechnol. 2007;18(6):497–503. doi:10.1016/j.copbio.2007.09.006
   PubMed Web of Science ®Google Scholar
• Jamali AA, Tavakoli A, Ezzati Nazhad Dolatabadi J. Analytical overview of DNA interaction with Morin and its metal complexes. Eur Food Res Technol. 2012;235(3):367–73. doi:10.1007/s00217-012-1778-8
   Web of Science ®Google Scholar
• Kang J, Li Z, Lu X. Electrochemical study on the behavior of Morin and its interaction with DNA. J Pharm Biomed Anal. 2006;40(5):1166–71. doi:10.1016/j.jpba.2005.08.030
   PubMed Web of Science ®Google Scholar
• Webb MR, Ebeler SE. Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity. Biochem J. 2004;384(Pt 3):527–41. doi:10.1042/BJ20040474
   PubMed Web of Science ®Google Scholar
• Nafisi S, Shadaloi A, Feizbakhsh A, Tajmir-Riahi HA. RNA binding to antioxidant flavonoids. J Photochem Photobiol B, Biol. 2009;94(1):1–7. doi:10.1016/j.jphotobiol.2008.08.001
   PubMed Web of Science ®Google Scholar
• Li HW, Bin ZT, Jia Q, Xia EQ, Cao WJ, et al. Anticancer effects of morin-7-sulphate sodium, a flavonoid derivative, in mouse melanoma cells. Biomed Pharmacother. 2016;84:909–916. doi:10.1016/j.biopha.2016.10.001
   PubMed Web of Science ®Google Scholar
• Sell S, Becker F, Leffert H, Osborn K, Salman J, et al. Alphafetoprotein as a marker for early events and carcinoma development during chemical hepatocarcinogenesis. In: Milman HA, Sell S, editors. Application of biological markers to carcinogen testing. Boston (MA): Springer US; 1983. p. 271–93. doi:10.1007/978-1-4613-3790-4
   Google Scholar
• Zimmer R, Thomas P. Mutations in the carcinoembryonic antigen gene in colorectal cancer patients: implications on liver metastasis. Cancer Res. 2001;61(7):2822–6. doi:10.1093/oxfordjournals.jjco.a038674
   PubMed Web of Science ®Google Scholar
• Becker FF, Sell S. Differences in serum alpha-fetoprotein concentrations during the carcinogenic sequences resulting from exposure to diethylnitrosamine or acetylaminofluorene. Cancer Res. 1979;39(5):1437–42.
   PubMed Web of Science ®Google Scholar
• Sivaramakrishnan V, Shilpa PNM, Praveen Kumar VR, Niranjali Devaraj S. Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin. Chem Biol Interact. 2008;171(1):79–88. doi:10.1016/j.cbi.2007.09.003
   PubMed Web of Science ®Google Scholar
• Kumar VK, Vennila S, Nalini N. Inhibitory effect of morin on DMH-induced biochemical changes and aberrant crypt foci formation in experimental colon carcinogenesis. Environ Toxicol Pharmacol. 2010;29(1):50–7. doi:10.1016/j.etap.2009.09.006
   PubMed Web of Science ®Google Scholar
• Karthik V, Vennila S, Nalini N. Modifying effects of morin on the development of aberrant crypt foci and bacterial enzymes in experimental colon cancer. Food Chem Toxicol. 2009;47(2):309–15. doi:10.1016/j.fct.2008.11.017
   PubMed Web of Science ®Google Scholar
• Wang J, Wu GS. Role of autophagy in cisplatin resistance in ovarian cancer cells. J Biol Chem. 2014;289(24):17163–73. doi:10.1074/jbc.M114.558288
   PubMed Web of Science ®Google Scholar
• Borst P, Rottenberg S, Jonkers J. How do real tumors become resistant to cisplatin? Cell Cycle. 2008;7(10):1353–9. doi:10.4161/cc.7.10.5930
   PubMed Web of Science ®Google Scholar
• Yang SH, Choi HG, Lim SJ, Lee MG, Kim SH. Effects of morin on the pharmacokinetics of etoposide in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in female Sprague-Dawley rats. Oncol Rep. 2013;29(3):1215–23. doi:10.3892/or.2012.2201
   PubMed Web of Science ®Google Scholar
• Kuzu M, Kandemir FM, Yildirim S, Kucukler S, Caglayan C, Turk E. Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis. Biomed Pharmacother. 2018;106:443–453. doi:10.1016/j.biopha.2018.06.161
   PubMed Web of Science ®Google Scholar
• Kuzu M, Yıldırım S, Kandemir FM, Küçükler S, Çağlayan C, Türk E, Dörtbudak MB. Protective effect of morin on doxorubicin-induced hepatorenal toxicity in rats. Chem Biol Interact. 2019;308:89–100. doi:10.1016/j.cbi.2019.05.017
   PubMed Web of Science ®Google Scholar
• Khadhim HA, Khudhair A-MH. The ameliorative effect of morin against methotrexate – Induced hepatotoxicity and some physiological and biochemical in male rats. Plant Arch. 2018;18(2):1503–11.
   Google Scholar
• Merwid-Ląd A, Ksiądzyna D, Hałoń A, Chlebda-Sieragowska E, Trocha M, Szandruk M, Sozański T, Magdalan J, Kopacz M, Kuźniar A, et al. Impact of morin-5′-sulfonic acid sodium salt on cyclophosphamide-induced gastrointestinal toxicity in rats. Pharmacol Rep. 2015;67(6):1259–63. doi:10.1016/j.pharep.2015.05.020
   PubMed Web of Science ®Google Scholar
• Bieg D, Sypniewski D, Nowak E, Bednarek I. Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin. Arch Gynecol Obstet. 2018;298(6):1181–94. doi:10.1007/s00404-018-4912-4
   PubMed Web of Science ®Google Scholar
• Singh MP, Cho HJ, Kim JT, Baek KE, Lee HG, et al. Morin hydrate reverses cisplatin resistance by impairing parp1/hmgb1-dependent autophagy in hepatocellular carcinoma. Cancers. 2019;11(7):986. doi:10.3390/cancers11070986
   Web of Science ®Google Scholar
• Li B, Jin X, Meng H, Hu B, Zhang T, Yu J, Chen S, Guo X, Wang W, Jiang W, et al. Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis. Oncotarget. 2017;8(29):47849–60. doi:10.18632/oncotarget.18133
   PubMedGoogle Scholar
• Shin SC, Piao YJ, Choi JS. Effects of morin on the bioavailability of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. In Vivo. 2008;22(3):391–5.
   Google Scholar
• Kok LD, Wong YP, Wu TW, Chan HC, Kwok TT, Fung KP. Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs. Life Sci. 2000;67(1):91–9. doi:10.1016/s0024-3205(00)00605-6
   PubMed Web of Science ®Google Scholar
• KV A, Madhana RM, Kasala ER, Samudrala PK, Lahkar M, Gogoi R. Morin hydrate mitigates cisplatin-induced renal and hepatic injury by impeding oxidative/nitrosative stress and inflammation in mice. J Biochem Mol Toxicol. 2016;30(12):571–9. doi:10.1002/jbt.21817
   PubMed Web of Science ®Google Scholar